Published in Nature on February 26, 2014
sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance. Nature (2016) 3.06
Immune cell promotion of metastasis. Nat Rev Immunol (2015) 2.15
IL-17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis. Nature (2015) 2.04
Neutrophils support lung colonization of metastasis-initiating breast cancer cells. Nature (2015) 1.94
Ultraviolet radiation accelerates BRAF-driven melanomagenesis by targeting TP53. Nature (2014) 1.85
The wound inflammatory response exacerbates growth of pre-neoplastic cells and progression to cancer. EMBO J (2015) 1.69
HMGB1 in health and disease. Mol Aspects Med (2014) 1.67
Innate immune pattern recognition: a cell biological perspective. Annu Rev Immunol (2015) 1.66
The melanoma revolution: from UV carcinogenesis to a new era in therapeutics. Science (2014) 1.37
The HMGB1/RAGE axis triggers neutrophil-mediated injury amplification following necrosis. J Clin Invest (2014) 1.35
Neutrophil-derived cytokines: facts beyond expression. Front Immunol (2014) 1.25
The melanocyte lineage in development and disease. Development (2015) 1.11
Neutrophils in cancer: neutral no more. Nat Rev Cancer (2016) 1.06
Cancer: Inflammation lights the way to metastasis. Nature (2014) 1.06
The experimental power of FR900359 to study Gq-regulated biological processes. Nat Commun (2015) 1.04
MITF and c-Jun antagonism interconnects melanoma dedifferentiation with pro-inflammatory cytokine responsiveness and myeloid cell recruitment. Nat Commun (2015) 1.01
Epigenetic regulation in human melanoma: past and future. Epigenetics (2015) 0.98
Pretreatment Neutrophil to Lymphocyte Ratio Independently Predicts Disease-specific Survival in Resectable Gastroesophageal Junction and Gastric Adenocarcinoma. Ann Surg (2016) 0.98
Molecular mechanism and therapeutic modulation of high mobility group box 1 release and action: an updated review. Expert Rev Clin Immunol (2014) 0.94
Angiotropism, pericytic mimicry and extravascular migratory metastasis in melanoma: an alternative to intravascular cancer dissemination. Cancer Microenviron (2014) 0.90
Ultraviolet radiation-induced non-melanoma skin cancer: Regulation of DNA damage repair and inflammation. Genes Dis (2014) 0.90
HMGB1, IL-1α, IL-33 and S100 proteins: dual-function alarmins. Cell Mol Immunol (2016) 0.89
The role of tissue resident cells in neutrophil recruitment. Trends Immunol (2015) 0.89
Melanoma cells revive an embryonic transcriptional network to dictate phenotypic heterogeneity. Front Oncol (2014) 0.88
Impact of the immune system and immunotherapy in colorectal cancer. J Gastrointest Oncol (2015) 0.87
Trial Watch: Immunostimulation with Toll-like receptor agonists in cancer therapy. Oncoimmunology (2015) 0.85
Imaging innate immune responses at tumour initiation: new insights from fish and flies. Nat Rev Cancer (2015) 0.85
Evaluating the Oxidative Stress in Inflammation: Role of Melatonin. Int J Mol Sci (2015) 0.84
Knockdown of HMGB1 improves apoptosis and suppresses proliferation and invasion of glioma cells. Chin J Cancer Res (2014) 0.83
Epistemology of the origin of cancer: a new paradigm. BMC Cancer (2014) 0.83
Genome-wide in vivo screen identifies novel host regulators of metastatic colonization. Nature (2017) 0.83
TNFα-activated mesenchymal stromal cells promote breast cancer metastasis by recruiting CXCR2(+) neutrophils. Oncogene (2016) 0.82
Neutrophils Oppose Uterine Epithelial Carcinogenesis via Debridement of Hypoxic Tumor Cells. Cancer Cell (2015) 0.82
Loss of epidermal p38α signaling prevents UVR-induced inflammation via acute and chronic mechanisms. J Invest Dermatol (2014) 0.82
Dynamic markers based on blood perfusion fluctuations for selecting skin melanocytic lesions for biopsy. Sci Rep (2015) 0.81
DAMPs, ageing, and cancer: The 'DAMP Hypothesis'. Ageing Res Rev (2014) 0.81
Aspirin delays mesothelioma growth by inhibiting HMGB1-mediated tumor progression. Cell Death Dis (2015) 0.81
The Diverse Biological Functions of Neutrophils, Beyond the Defense Against Infections. Inflammation (2016) 0.80
Upregulated LINE-1 Activity in the Fanconi Anemia Cancer Susceptibility Syndrome Leads to Spontaneous Pro-inflammatory Cytokine Production. EBioMedicine (2016) 0.80
Tumour hypoxia promotes melanoma growth and metastasis via High Mobility Group Box-1 and M2-like macrophages. Sci Rep (2016) 0.79
Edge effects in game-theoretic dynamics of spatially structured tumours. J R Soc Interface (2015) 0.79
Pericytic mimicry in well-differentiated liposarcoma/atypical lipomatous tumor. Hum Pathol (2016) 0.79
"Glowing head" mice: a genetic tool enabling reliable preclinical image-based evaluation of cancers in immunocompetent allografts. PLoS One (2014) 0.79
Inflammation and skeletal metastasis. Bonekey Rep (2015) 0.79
Imaging of Angiotropism/Vascular Co-Option in a Murine Model of Brain Melanoma: Implications for Melanoma Progression along Extravascular Pathways. Sci Rep (2016) 0.78
Modeling synovial sarcoma metastasis in the mouse: PI3'-lipid signaling and inflammation. J Exp Med (2016) 0.78
Immunity in arterial hypertension: associations or causalities? Nephrol Dial Transplant (2015) 0.78
Exploiting the Immunomodulatory Properties of Chemotherapeutic Drugs to Improve the Success of Cancer Immunotherapy. Front Immunol (2015) 0.78
Personal history of psoriasis and risk of incident cancer among women: a population-based cohort study. Br J Dermatol (2016) 0.78
Identifying mutation specific cancer pathways using a structurally resolved protein interaction network. Pac Symp Biocomput (2015) 0.78
Cross-species models of human melanoma. J Pathol (2015) 0.77
Genetically engineered mouse models in oncology research and cancer medicine. EMBO Mol Med (2016) 0.77
Human breast cancer biopsies induce eosinophil recruitment and enhance adjacent cancer cell proliferation. Breast Cancer Res Treat (2016) 0.77
Neutrophils: Critical components in experimental animal models of cancer. Semin Immunol (2016) 0.77
Activation of α7 Nicotinic Acetylcholine Receptor Decreases On-site Mortality in Crush Syndrome through Insulin Signaling-Na/K-ATPase Pathway. Front Pharmacol (2016) 0.77
Triggering Receptor Expressed on Myeloid Cells in Cutaneous Melanoma. Clin Transl Sci (2015) 0.77
The red-vine-leaf extract AS195 increases nitric oxide synthase-dependent nitric oxide generation and decreases oxidative stress in endothelial and red blood cells. Pharmacol Res Perspect (2016) 0.77
Phorbol ester-induced neutrophilic inflammatory responses selectively promote metastatic spread of melanoma in a TLR4-dependent manner. Oncoimmunology (2015) 0.77
Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cells. Nat Immunol (2017) 0.76
Lupus erythematosus revisited. Semin Immunopathol (2015) 0.76
Immune Cells in Cancer Therapy and Drug Delivery. Mediators Inflamm (2016) 0.75
The epidermal polarity protein Par3 is a non-cell autonomous suppressor of malignant melanoma. J Exp Med (2017) 0.75
Tumour immunology: inflaming tumour spread. Nat Rev Immunol (2014) 0.75
Tumour microenvironment: more than just a mutagen. Nat Rev Cancer (2014) 0.75
Targeting cancer-related inflammation in the era of immunotherapy. Immunol Cell Biol (2017) 0.75
UV and melanoma: the TP53 link. Cell Res (2014) 0.75
Molecular pathways: not a simple tube--the many functions of blood vessels. Clin Cancer Res (2014) 0.75
Resatorvid-based Pharmacological Antagonism of Cutaneous TLR4 Blocks UV-induced NF-κB and AP-1 Signaling in Keratinocytes and Mouse Skin. Photochem Photobiol (2016) 0.75
Lymphatic invasion and angiotropism in primary cutaneous melanoma. Lab Invest (2016) 0.75
Mouse models of UV-induced melanoma: genetics, pathology, and clinical relevance. Lab Invest (2017) 0.75
Self-assembly of c-myc DNA promoted by a single enantiomer ruthenium complex as a potential nuclear targeting gene carrier. Sci Rep (2016) 0.75
A light shines on melanoma metastagenesis. Pigment Cell Melanoma Res (2014) 0.75
Recent advances in understanding neutrophils. F1000Res (2016) 0.75
Immune Regulation of the Metastatic Process: Implications for Therapy. Adv Cancer Res (2016) 0.75
ATR Mutations Promote the Growth of Melanoma Tumors by Modulating the Immune Microenvironment. Cell Rep (2017) 0.75
The Response of microRNAs to Solar UVR in Skin-Resident Melanocytes Differs between Melanoma Patients and Healthy Persons. PLoS One (2016) 0.75
So You Can Teach Old Fibroblasts New Tricks. Cancer Discov (2016) 0.75
Ultraviolet-induced alloantigen-specific immunosuppression in transplant immunity. World J Transplant (2015) 0.75
Effect of trapping vascular endothelial growth factor-A in a murine model of dry eye with inflammatory neovascularization. Int J Ophthalmol (2016) 0.75
Deep-proteome mapping of WM-266-4 human metastatic melanoma cells: From oncogenic addiction to druggable targets. PLoS One (2017) 0.75
The controversial role of TNF in melanoma. Oncoimmunology (2015) 0.75
Structural decoding of netrin-4 reveals a regulatory function towards mature basement membranes. Nat Commun (2016) 0.75
Genetically engineered mouse models of melanoma. Cancer (2017) 0.75
Intracellular HMGB1 as a novel tumor suppressor of pancreatic cancer. Cell Res (2017) 0.75
Estimating the annual frequency of synchronous brain metastasis in the United States 2010-2013: a population-based study. J Neurooncol (2017) 0.75
Mouse versus Human Neutrophils in Cancer: A Major Knowledge Gap. Trends Cancer (2017) 0.75
Immunoplasticity in cutaneous melanoma: beyond pure morphology. Virchows Arch (2017) 0.75
Clinical responses to adoptive T-cell transfer can be modeled in an autologous immune-humanized mouse model. Nat Commun (2017) 0.75
CBP501 suppresses macrophage induced cancer stem cell like features and metastases. Oncotarget (2017) 0.75
Plasticity of tumour and immune cells: a source of heterogeneity and a cause for therapy resistance? Nat Rev Cancer (2013) 1.61
CD8(+) T Cells Orchestrate pDC-XCR1(+) Dendritic Cell Spatial and Functional Cooperativity to Optimize Priming. Immunity (2017) 0.78
Reactive Neutrophil Responses Dependent on the Receptor Tyrosine Kinase c-MET Limit Cancer Immunotherapy. Immunity (2017) 0.75
Improved heart repair upon myocardial infarction: Combination of magnetic nanoparticles and tailored magnets strongly increases engraftment of myocytes. Biomaterials (2017) 0.75